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IgE-Mediated Sensitization to Malassezia in
Atopic Dermatitis: More Common in Male
Patients and in Head and Neck Type
Petra Brodska´, MD,*† Petr Panzner, Assoc Prof,‡ Karel Pizinger, Prof,* and Peter Schmid-Grendelmeier, Prof†
Background: Atopic dermatitis (AD) is a common chronic inflammatory skin disease. Malassezia, the predominant
skin microbiota fungus, is considered to exacerbate AD, especially in a subset of patients with head and neck type AD
(HNAD). In the present study, the relationship between AD and sensitization to Malassezia antigens was investigated.
Methods: We assessed 173 patients with AD. The severity of eczema was determined with Eczema Area and Severity
Index (EASI); the type of AD, namely, head and neck type, was reported as well. The total serum IgE and specific IgE to
Malassezia were determined and correlated with clinical picture of AD, sex, age, and the EASI.
Results: Total IgE was elevated in 77.7% of patients. Specific IgE to Malassezia was positive (Q0.35 kU/L) in 49.1%
of patients. Men were significantly more often sensitized to Malassezia antigen (58% of men vs 42% of women;
P value, 0.04). Concurrently, 58% of patients with HNAD versus 42% non-HNAD patients had higher levels of specific IgE
to Malassezia, this difference being nearly significant (P value, 0.06). Patients with atopy were also more frequently
sensitized toMalassezia. No significant relationship between EASI and the level of total IgE or specific IgE toMalassezia
was observed.
Conclusions: In our population, IgE-mediated sensitization was found in up to 49% of all patients with AD, most
common in men and in head and neck type.
Atopic dermatitis (AD) is a common chronic inﬂammatoryskin disease that exhibits repeated periods of remission and
deterioration.1 It affects 10% to 20% of children and 1% to 3% of
adults in industrialized countries and its prevalence still rises.
Atopic dermatitis usually begins within the ﬁrst 2 years of life.
Numerous IgE-inducing allergens play a role in the pathogenesis
of AD. In fact, speciﬁc IgE antibodies against environmental al-
lergens such as mites and various food allergens are detectable
in sera of patients with AD.1 Most patients with AD develop IgE
sensitizations to various allergens during the course of the disease.
The earliest sensitization to food allergens in children with AD
occurs already in the ﬁrst years of life, whereas sensitization to
aeroallergens develops later, which is parallel with the progress
of the atopic march.2Y4 The opportunistic yeast Malassezia spe-
cies (formerly known as Pityrosporum) belongs to the normal
cutaneous ﬂora. Malassezia can also cause IgE-mediated sensiti-
zation in patients experiencing AD. Sensitization to microbial
allergens seems to occur later in the course of AD than sensiti-
zation to food allergens and aeroallergens.5 The role of the speciﬁc
IgE in the pathogenesis of AD and its value as a marker for the
severity of eczema are not completely understood.5
The impaired epidermal barrier and the altered immune system
facilitate the penetration of allergens through the skin and their
subsequent recognition by receptors. This results in enhanced
release of IL4, IL5, and IL13 and increased production of IgE.6
As a result, 50% of children7 and 80% of adults8 with AD have
elevated levels of total serum IgE. Some studies show a statistical
correlation between total IgE levels and the severity of eczema.9Y12
However, 20% of patients with manifest AD have never exhibited
elevated serum levels of total or speciﬁc IgE,13 the eczema in pa-
tients with very high IgE levels does not necessarily improve after
the treatment with anti-IgE antibodies,14 and the total IgE does
not correlate with the severity of eczema in many patients.15 Thus,
the correlation between total or speciﬁc IgE and the severity of
eczematous skin lesions in patients with AD is still controversial.
Approximately 50 fungal species colonize the skin of patients
with AD,16 the predominant fungus being the lipophilic yeast
Malassezia. Concurrently, among the group of fungal allergens,
sensitization to Malassezia species seems to be the most impor-
tant, when compared with the relatively low sensitization rates for
Candida albicans andCladosporium herbarum.5Malassezia colonizes
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sebum-rich areas such as head, face, and neck rather than limbs
or trunk because this microorganism requires human skin lipids
in sebum for growth. The sebum production is high in the ﬁrst
3 months of life, then decreases in childhood and again increases
during puberty until the age of 50 years.17 Therefore, age plays an
important part in skin colonization with Malassezia species.
Atopic dermatitis of the head and neck (HNAD) is recognized
as a separate condition. Patients with HNAD are more likely to
have positive skin-prick test (SPT) results and Malassezia-speciﬁc
IgE compared with healthy control subjects and patients with
atopy without HNAD.18 The reaction toMalassezia is likely related
to both humoral- and cell-mediated immunities.18 Clinically,
Malassezia allergy may be suspected in patients with AD and in (1)
head and neck lesions, (2) exacerbations during adolescence or
young adulthood caused by increased sebaceous gland activity
supporting Malassezia colonization, (3) severe lesions recalcitrant
to conventional therapy, and (4) other atopic diseases.18 There are
some reports suggesting that these patients will beneﬁt from
antimycotic therapy.18Y20
PATIENTS AND METHODS
Patients
We assessed 173 patients (96 women and 77 men) with AD seen in
years 2011 and 2012 at the Department of Dermatology, University
Hospital in Zu¨rich. The only inclusion criterion was the presence of
AD. The diagnosis of AD was conﬁrmed by a dermatologist in each
patient according to the clinical criteria of Haniﬁn and Rajka. The
subgroup of patients with AD with primarily head, neck, and upper
torso pattern of dermatitis was considered as patients with HNAD.
The severity of eczema was assessed by a dermatologist using the
EczemaArea and Severity Index (EASI) during a random visit of the
patient at theDepartment ofDermatology inZu¨rich. The intensity of
erythema, thickness (induration, papulation, edema), excoriation,
licheniﬁcation, and the approximate percentage affected by eczema
were calculated for each region.
Testing of IgE Antibodies
Serum sample was drawn from each patient for determination of
total serum IgE and speciﬁc IgE. Speciﬁc IgE against Malassezia
mix (m227), a mixture of 3 Malassezia species (Malassezia
sympodialis, Malassezia globosa, and Malassezia restricta), was
analyzed in all patients. When atopy was suspected (in 143 pa-
tients), speciﬁc IgE values against airborne and food allergens were
also analyzed. Allergen-speciﬁc values of greater than or equal to
0.35 kU/L were regarded as positive. The samples of 133 patients
were also analyzed for the presence of total IgE antibodies using
the ImmunoCAP, a ﬂuorescence enzyme immunosorbent assay
(Thermo Fisher Scientiﬁc, formerly Phadia). Total serum IgE of
greater than or equal to 100 kU/L was considered as elevated. The
assessor was blinded to the outcome of the IgE results at themoment
of classiﬁcation into the HNAD or the non-HNAD group.
TABLE 1. Clinical Characteristics of All Patients in Regard of Sex and Head/Neck Type
All Female Male HNAD Non-HNAD
Patients total 173 55.5% (96/173) 44.5% (77/173) 42.8% (74/173) 57.2% (99/173)
Mean age, y 37.6 37.3 38.3 37.5 37.6
Age groups, y
4Y25 28.9% (50/173) 28.1% (27/96) 29.9% (23/77) 27% (20/74) 30.3% (30/99)
25Y84 71.1% (123/173) 71.9% (69/96) 70.1% (54/77) 73% (54/74) 69.7% (69/99)
Median total IgE, kU/L* 407 255 1131 637 295
P value: G0.001 P value: 0.06
Elevated total IgE (Q100 kU/L)* 77.7% (94/133) 62.5% (45/72) 80.3% (49/61) 82.4% (42/51) 63.4% (52/82)
P value: 0.04 P value: 0.69
Median sp IgE Malassezia, kU/L 0.25 0.1 0.57 1.3 0.13
P value: G0.001 P value: G0.001
Positive sp IgE Malassezia (Q0.35 kU/L) 49.1% (85/173) 41.7% (40/96) 58.4% (45/77) 58.1% (43/74) 42.4% (42/99)
P value: 0.04 P value: 0.06
Atopy† (positive sp IgE to airborne
or food allergens)
68.5% (98/143) 59% (46/78) 80% (52/65) 71.2% (42/59) 66.7% (56/84)
P value: 0.01 P value: 0.7
HNAD 42.8% (74/173) 35.4% (34/96) 51.9% (40/77)
P value: 0.04
Sex
Female 46% (34/74) 62.6% (62/99)
Male 54% (40/74) 37.4% (37/99)
A P value of less than 0.05 was considered to be significant.
HNAD indicates head and neck atopic dermatitis; sp IgE, specific IgE; y, years.
*Total IgE (Q100 kU/L) was not evaluated in 40 patients (24 women and 16 men; 23 HNAD and 17 non-HNAD).
†Atopy was not evaluated in 30 patients (18 women and 12 men; 15 HNAD and 15 non-HNAD).
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Statistical Analysis
Continuous data of nonparametric distribution are presented as
median values; the variability of the data was characterized by
minimum-maximum intervals and ﬁrst and third quartile range.
Differences between groups were calculated by means of Mann-
Whitney-Wilcoxon test. Differences in proportions between
groups were tested by Pearson W2 test. P values of less than or equal
to 0.05 were considered statistically signiﬁcant.
RESULTS
The clinical characteristics of patients are summarized in
Tables 1 and 2.
We assessed 173 patients with AD (96 women and 77 men).
Median total serum IgE was 407 kU/L. Elevated total IgE
(Q100 kU/L) was detected in 77.7% of patients. Speciﬁc IgE to
Malassezia was detected in 49.1% of patients. Atopy (positivity of
speciﬁc IgE to airborne or food allergens) was found in 68.5% of
patients. Men were signiﬁcantly more often sensitized toMalassezia
antigens and had signiﬁcantly higher levels of speciﬁc IgE to
Malassezia than women (Fig. 1). Concurrently, men had signiﬁ-
cantly more often elevated total IgE (Q100 kU/L) and also had
higher levels of total IgE (Fig. 2). We found atopy signiﬁcantly
more often in men than in women. Men also experienced HNAD
signiﬁcantly more often than women.
We divided the patients into 2 groups, according to clinical
picture of AD. Seventy-four (42.8%) patients experienced HNAD
with predominant involvement of the face, scalp, and upper torso.
Ninety-nine (57.2%) patients had a more generalized form of AD
or dermatitis on hands or feet, which does not involve the head and
especially the neck area. In the non-HNAD group, minimal ec-
zematous lesions in small areas with typical AD locations (eg,
eyelid, retroauricular) at some time points were present; however,
no neck involvement at all and no major involvement of the face
(G10% of the surface of the face) was allowed in this group.
Patients with HNAD had signiﬁcantly higher levels of
Malassezia-speciﬁc IgE (Fig. 3). We observed only a trend to more
frequent sensitization to Malassezia antigens and to higher levels
of total IgE in patients with HNAD (Fig. 4). Atopy occurs with
approximately equal frequency in both groups (HNAD and non-
HNAD). We divided the patients into 2 age groups. Fifty patients
belonged in the group of children and young adults (ages, 4Y25 years;
9 prepubertal children were 12 years or younger) and 123 patients
were older than 25 years. Atopy was signiﬁcantly more often
present in children and young adults. We observed no other sig-
niﬁcant differences in these 2 age groups.
Positive speciﬁc IgE to airborne or food allergens was found in
68.5% of patients. In these patients, we observed signiﬁcantly
higher levels and more frequent positive speciﬁc IgE toMalassezia
antigens (Fig. 5). There was no difference in frequency of atopy
between patients with HNAD and patients with skin lesions in
other localizations.
TABLE 2. Clinical Characteristics and Sensitization Patterns According to Age and Atopy
0Y25 y 925 y Atopy Without Atopy
Patients total 28.9% (50/173) 71.1% (123/173) 68.5% (98/143) 31.5% (45/143)
Mean age, y 18.6 45.5 37.2 41.4
Sex
Female 54% (27/50) 56.1% (69/123) 46.9% (46/98) 71.1% (32/45)
Male 46% (23/50) 43.9% (54/123) 53.1% (52/98) 28.9% (13/45)
Median total IgE, kU/L* 368 453 1226 44.35
P value: 0.39
Elevated total IgE (Q100 kU/L)* 64.7% (22/34) 72.7% (72/99) 76.5% (75/98) 22.2% (10/45)
P value: 0.12
Median sp IgE Malassezia, kU/L 0.64 0.23 1.52 0
P value: 0.26 P value: G0.001
Positive sp IgE Malassezia (Q0.35 kU/L) 56% (28/50) 46.3% (57/123) 68.4% (67/98) 11.1% (5/45)
P value: 0.33 P value: G0.001
Atopy† (positive sp IgE to airborne
or food allergens)
84.6% (33/39) 62.5% (65/104)
P value: 0.02
HNAD 40% (20/50) 43.9% (54/123) 42.9% (42/98) 37.8% (17/45)
P value: 0.76
Age groups, y
0Y25 33.7% (33/98) 13.3% (6/45)
25Y84 66.3% (65/98) 86.7% (39/45)
A P value of less than 0.05 was considered to be significant.
HNAD indicates head and neck atopic dermatitis; sp IgE, specific IgE; y, years.
*Total IgE (Q100 kU/L) was not evaluated in 40 patients (0Y25 years not applicable in 16 patients, and 25Y84 years not applicable in 24 patients).
†Atopy was not evaluated in 30 patients (0Y25 years not applicable in 11 patients and 25–84 years not applicable in 19 patients; 18 women and 12 men; 15 HNAD and
15 non-HNAD).
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EczemaArea and Severity Index was evaluated only in 32 patients,
and themean EASI was 23.1. Most patients were diagnosed withmild
to moderate eczema.We did not ﬁnd signiﬁcant relationship between
EASI and speciﬁc IgE to Malassezia or levels of total IgE.
DISCUSSION
Barrier function defect is a result of altered ﬁlaggrin, increased pH,
decreased antimicrobial secretions, decreased IgA, and decreased
sweat production.21 The alkaline pH may stimulate the release of
antigens fromMalassezia, and the decreased antimicrobial peptides
may allow Malassezia to grow.21 In response to dense Malassezia
colonization, keratinocytes produce T-helper 2 cytokines and che-
mokines and the local antigen-presenting cells (APCs) are activated.
The activated APCs take up Malassezia antigens and present them
to T cells. T cellYAPC interactions result in T-cell activation and
production of additional T-helper 2 cytokines and chemokines and
Figure 2. Comparison of total IgE in relation to sex.
Figure 3. Comparison of specific IgE against Malassezia (Mala) in
relation to head and neck type.Figure 1. Comparison of specific IgE against Malassezia (Mala) in
relation to sex.
Figure 4. Comparison of total IgE in relation to head and neck type.
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up-regulationof adhesionmolecules. Thismay lead to inﬂux ofmore
leukocytes into Malassezia-colonized skin, resulting in increased
inﬂammation in the densely Malassezia-colonized areas causing
the clinical entity of HNAD.18 During this process, B cells are also
stimulated by APCs and T-helper 2 cytokines. This results in iso-
type switching and production of Malassezia-speciﬁc IgE. Table 3
summarizes the possible effects and interaction of Malassezia and
worsening of skin barrier.
Given the widely accepted multifactorial cause of AD, it is
unlikely that immunologic reactions against Malassezia would be
a single causative factor of HNAD. However, it could become a
triggering factor. There is no convincing evidence that the skin of
patients with AD is more heavily colonized with Malassezia or is
colonized with different species ofMalassezia, when compared with
healthy control subjects or patients with seborrheic dermatitis.
Many studies have tried to ﬁnd a different pattern of Malassezia
colonization of AD skin, which is not present on healthy skin.22Y27
However, the published results are controversial.18 The challenges
of proper sampling, in vitro culture, and correct identiﬁcation of
Malassezia species could be the reason for conﬂicting results. Nev-
ertheless, compared with healthy control subjects, patients with at-
opy are more likely to develop an immune response after exposure
to any antigen.18 Several studies have shown that patients with AD
react more frequently to Malassezia antigens on SPTs and exhibit
higher levels of Malassezia-speciﬁc IgE compared with healthy
control subjects.28Y31 Focusing on the subset of patientswithHNAD,
research has shown that these patients tend to have higher rates of
positive SPT results and higher levels of Malassezia-speciﬁc IgE
when compared with patients who have AD without HNAD.29,32Y34
This corresponds also to our results. One of the larger studies en-
rolled 589 patients and found that 100% of patients with HNAD
had increased Malassezia-speciﬁc IgE compared with only 13%
of patients with AD without HNAD.35 Our results are not so
convincing. In our investigation, 58.1% of patients with HNAD
and 42.4% of patients with AD without HNAD had increased
Malassezia-speciﬁc IgE. Two former studies have even reported a
correlation between Malassezia-speciﬁc IgE levels and the clinical
severity of HNAD.34,35 In contrast to these results, we could not
conﬁrm that higher total IgE or speciﬁc IgE to Malassezia would
serve as markers for more severe eczema. We did not ﬁnd a sig-
niﬁcant relationship between EASI and speciﬁc IgE to Malassezia.
This may be due to the limited number of patients with EASI
scoring involved in our study. Nevertheless, we assume that the
more severe disease leads to higher likelihood of sensitization.
Studies of SPT and speciﬁc IgE suggest that the immune system
of patients with AD recognizes Malassezia antigens and induces a
B-cellYmediated humoral response against these antigens.18 In
contrast, the atopy patch test (APT) assesses the T-cellYmediated
response to an antigen. In any case, T-cell mediation is critical to
dermatitis, which is a delayed-type hypersensitivity response, but
also by leading to TH2 responses favoring sensitization in AD.36 The
use of the APT in Malassezia-mediated sensitization in AD is
somewhat controversial. Some studies suggest that APT is more
speciﬁc than tests for antigen-speciﬁc IgE.37 In another study, APT
was a less sensitive test for demonstrating Malassezia-speciﬁc
IgE-mediated immune response.18 However, in other studies, no
TABLE 3. Possible Effects of Malassezia Colonization and Skin Function in AD
Skin Function in AD Malassezia Colonization
Skin barrier Impaired by various factors such as
filaggrin deficiency
Activation of mast cell IgE responses leading to increased
skin inflammation with possible association with48
Allows presentation of Malassezia to
immune system
worsening of skin barrier function
pH Alkaline pH stimulates growth of Malassezia
and increased expression of allergens.21
Effect on keratinocytes Production of T-helper 2 cytokines
Activation of APCs
Up-regulation of chemokines and adhesion molecules
AD indicates atopic dermatitis; APCs, antigen-presenting cells.
Figure 5. Comparison of specific IgE against Malassezia (Mala) in
relation to atopy or nonatopy.
124 DERMATITIS, Vol 25 ¡ No 3 ¡ May/June, 2014
Copyright © 2014 American Contact Dermatitis Society. Unauthorized reproduction of this article is prohibited.
correlation between tests for antigen-speciﬁc IgE and APT was
found.38 It is possible that systemic and topical antiyeast therapies
would be most effective in patients with cutaneous hypersensi-
tivity toMalassezia as demonstrated in positive APT.38 Thus, also,
APT in Malassezia sensitizations might have a relevant role in
the workup of AD. Some of the variability seen in the results
of different studies may be related to the different methods of
Malassezia culture, conditions, extract storage, and selection of
antigens. The stability of Malassezia extracts has been reported
to be poor, even when stored at +4-C, and it is recommended
that storage should not exceed more than 1 month.39 It is also
recommended that culture extracts containing the highest number
of antigenic proteins should be used in clinical testing to avoid false-
negative results. In our study, Malassezia mix (m227) representing
3 different species was used. This allowed the detection of more
Malassezia-sensitized individuals than does the analysis of speciﬁc
IgE to M. sympodialis (m70) only.
Recent literature describes elevated total IgE in roughly 80%
of adults and 50% children with AD.7,8 Concerning the fungal
allergens tested in our investigation, previous studies found sen-
sitization toMalassezia species in 12% to 17% of children40Y42 and
in 29% to 65% of adults.31,43 The considerably higher rate of
sensitization in adults than in children described in previous stu-
dies was probably due to the longer disease history with a higher
time-dependent probability to develop multiple sensitizations in
adults.10 In contrast, in our study, we did not ﬁnd signiﬁcant cor-
relation between age and total IgE or sensitization to Malassezia
species. We observed only a trend to more frequent elevated total
IgE in older patients, surprisingly with an opposite trend con-
cerning speciﬁc IgE to Malassezia.
CONCLUSIONS
In our study, nearly half of patients with AD were sensitized to
Malassezia antigen. We found that men and patients with HNAD
were more frequently sensitized to Malassezia antigens and also
had signiﬁcantly higher levels of speciﬁc IgE to Malassezia.
Sebaceous gland activity is increased in men and in sebum-rich
areas such as head, face, and neck, so our results support the
seborrhea-dependent theory of Malassezia sensitization. Obvi-
ously, IgE-mediated sensitization against Malassezia is not the
single causative factor of AD, but it could act as a triggering fac-
tor. However, there is a close interaction between the presence of
Malassezia and the factors inﬂuencing skin in AD such as pH, the
barrier function, or bioﬁlm composition.44,45 The reduction or
elimination of triggering microbial factors on the skin, for example,
by using antifungals,46,47 in combination with anti-inﬂammatory
and emollient therapy, may decrease the immune and inﬂamma-
tory response and considerably improve the clinical course of AD.
Recent studies have involved populations from other regions
(eg, Scandinavia,25 United States of America,5 or Asian populations1).
Our study conﬁrms the ﬁndings of previous studies but also
describes for the ﬁrst time a more central European (Swiss) pop-
ulation including the aspects of HNAD/non-HNAD.
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